Skip to main content
. 2024 Apr 3;13(5):e230178. doi: 10.57264/cer-2023-0178

Figure 2. . Incremental cost–effectiveness ratio and price reduction according to clinical benefit.

Figure 2. 

(A) Median ICER according to clinical benefit of the oncology product. (B) Recommended list price reductions according to clinical benefit of the oncology product. $ are in CAD.

CADTH: Canadian Agency of Drugs and Technologies in Health; ICER: Incremental cost–effectiveness ratio.